Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Supergenics

Market Cap 29.11M 7.19M 6.2M 5.7M 5.35M 10.05M 679M 10.15M 67.41M 26.33M 333M 26.97M 26.4M 1.15B P/E Ratio 2024
-9.45x
P/E Ratio 2025 -8.61x
Enterprise Value 32.5M 8.03M 6.92M 6.37M 5.97M 11.22M 759M 11.33M 75.27M 29.4M 371M 30.12M 29.48M 1.29B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 day+21.95%
6 months+21.95%
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 24/04/2019
Corporate Secretary - 02/06/2022
Director TitleAgeSince
Director/Board Member 48 24/04/2019
Director/Board Member 60 24/04/2019
Director/Board Member 46 28/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%-15.25% 7.19M
-0.24%-0.34%-12.95%-13.04% 43.58B
-3.55%+3.36%+288.67%+527.84% 34.03B
+0.15%-4.29%+11.94%-17.48% 29.77B
-0.44%-0.28%+1.13%+33.57% 29.82B
-0.29%+9.47%+13.95%+21.93% 25.42B
+2.79%+7.13% - - 13.87B
-1.36%-1.40%+52.92%+107.50% 13.35B
-1.04%-3.48%+2.42%+1.98% 12.85B
-1.48%-2.45%+106.46%+77.36% 12.22B
Average +1.66%+1.83%+49.76%+80.49% 21.49B
Weighted average by Cap. -0.73%+2.02%+59.89%+103.64%

Financials

2024 2025
Net sales 5.32M 1.31M 1.13M 1.04M 978K 1.84M 124M 1.86M 12.32M 4.81M 60.82M 4.93M 4.83M 210M 5.63M 1.39M 1.2M 1.1M 1.03M 1.94M 131M 1.96M 13.03M 5.09M 64.29M 5.21M 5.1M 222M
Net income -7.28M -1.8M -1.55M -1.43M -1.34M -2.51M -170M -2.54M -16.86M -6.59M -83.21M -6.75M -6.6M -288M -3.37M -831K -716K -659K -618K -1.16M -78.55M -1.17M -7.79M -3.04M -38.47M -3.12M -3.05M -133M
Net Debt 4.48M 1.11M 953K 877K 823K 1.55M 104M 1.56M 10.37M 4.05M 51.17M 4.15M 4.06M 177M 3.39M 838K 722K 665K 624K 1.17M 79.21M 1.18M 7.86M 3.07M 38.79M 3.15M 3.08M 134M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!